Signature

Signature Biologics is a regenerative medicine company focused on developing and manufacturing innovative perinatal tissue-derived products. The company leverages proprietary processing methods to preserve the natural biological integrity of umbilical cord and amniotic tissues, creating therapies intended to support tissue repair and reduce inflammation. Their product portfolio includes injectable biologics and structural tissues used in orthopedics, wound care, and pain management. Signature Biologics operates a cGMP-compliant manufacturing facility to ensure the highest standards of safety and efficacy for their human cell and tissue-based products (HCT/Ps).